Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?

doi:10.1186/1475-2875-6-16

Malaria Journal

Volume 6

Viewing options:

Abstract
Full text
PDF (424KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Vallely A
Vallely L
Changalucha J
Greenwood B
Chandramohan D

on PubMed

Vallely A
Vallely L
Changalucha J
Greenwood B
Chandramohan D
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Review

Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?

Andrew Vallely¹^,2 , Lisa Vallely¹ , John Changalucha¹ , Brian Greenwood² and Daniel Chandramohan²

¹National institute for Medical Research, Mwanza Centre, PO Box 1462, Mwanza, Tanzania

²London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK

author email corresponding author email

Malaria Journal 2007, 6:16doi:10.1186/1475-2875-6-16


Published:	16 February 2007

Abstract

Falciparum malaria is an important cause of maternal, perinatal and neonatal morbidity in high transmission settings in Sub-Saharan Africa. Intermittent preventive treatment with sulphadoxine-pyrimethamine (SP-IPT) has proven efficacious in reducing the burden of pregnancy-associated malaria but increasing levels of parasite resistance mean that the benefits of national SP-IPT programmes may soon be seriously undermined in much of the region. Hence, there is an urgent need to develop alternative drug regimens for IPT in pregnancy. This paper reviews published safety and efficacy data on various antimalarials and proposes several candidate combination regimens for assessment in phase II/III clinical trials.